OnePin Peptide Library · Longevity
Epithalon
Epitalon · AEDG · Epithalamin
Epithalon (also spelled Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It is a Khavinson bioregulator, a class of short peptides that regulate gene expression in specific tissues at very low concentrations. Epithalon targets the pineal gland and activates telomerase, the enzyme responsible for maintaining telomere length on chromosomal ends. Telomere shortening is one of the primary hallmarks of cellular aging. Epithalon is the synthetic analog of Epithalamin, a peptide extract originally derived from bovine pineal gland. It is administered in short, intensive courses (10-20 days) rather than continuously, consistent with Khavinson's bioregulatory dosing philosophy.
Evening/bedtime dosing preferred (pineal gland targeting, melatonin relationship). 10-20 day courses. Pin alone.
Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.
How it works
Epithalon activates the catalytic subunit of telomerase (hTERT) in somatic cells, enabling the enzyme to add telomeric repeats (TTAGGG) to chromosomal ends. This counteracts the progressive telomere shortening that occurs with each cell division and is one of the recognized hallmarks of aging. Epithalon also normalizes pineal gland function, restoring melatonin production patterns that decline with age. Melatonin itself has antioxidant and immunomodulatory properties. As a Khavinson bioregulator, Epithalon works through gene expression regulation at very low concentrations, interacting with DNA at the level of histone modification and transcription factor accessibility rather than through traditional receptor binding. This mechanism explains why bioregulators are administered in short intensive courses followed by extended rest periods.
Epithalon activates the catalytic subunit of telomerase (hTERT) in somatic cells, enabling the enzyme to add telomeric repeats (TTAGGG) to chromosomal ends. This counteracts the progressive telomere shortening that occurs with each cell division and is one of the recognized hallmarks of aging. Epithalon also normalizes pineal gland function, restoring melatonin production patterns that decline with age. Melatonin itself has antioxidant and immunomodulatory properties. As a Khavinson bioregulator, Epithalon works through gene expression regulation at very low concentrations, interacting with DNA at the level of histone modification and transcription factor accessibility rather than through traditional receptor binding. This mechanism explains why bioregulators are administered in short intensive courses followed by extended rest periods.
What to expect
Days 1-10 (during course): Sleep quality improvements may be noticeable (pineal/melatonin normalization). Gene expression changes are initiated but not yet manifested clinically. Course is only 10-20 days.
Weeks 2-12 (after course): Gene expression changes continue to manifest. Telomerase activation effects persist beyond the dosing period. Sleep improvements may sustain.
Months 3-12: Cumulative effects across multiple courses. Telomere length measurements (if tracked) may show stabilization or modest lengthening over time. Best assessed through longitudinal biomarker tracking.
Evidence
The honest take
Telomerase activation
SupportedConfirmed in multiple cell culture studies showing hTERT activation and telomere elongation. The mechanism is well-supported. Whether this translates to meaningful anti-aging effects in humans requires long-term data.
Animal studies show approximately 25% lifespan increase in rodents. One of the few compounds with lifespan data. Not confirmed in humans.
Animal data shows normalization of melatonin production in aged animals. Consistent with Khavinson's bioregulatory theory of organ-specific gene expression restoration.
Interactions & stacking
What's safe to combine, and what belongs in a separate pin.
Safe & synergistic
Keep separate
Side effects & safety
Commonly reported
- Very well tolerated
- Mild injection site irritation
- No significant side effects reported in published literature
Less common & notes
- Epithalon is a small tetrapeptide with a clean safety profile in published research.
- The short course duration (10-20 days) limits cumulative exposure.
- Theoretical concern about telomerase activation in cancer cells, though animal studies actually showed reduced tumor incidence.
- Individuals with active malignancy should consult their oncologist before use.
Pharmacokinetics
Storage. Store unreconstituted vials frozen (-20C) or refrigerated (2-8C). After reconstitution with BAC water, refrigerate at 2-8C. Stable for 28-30 days. Small tetrapeptide with favorable stability. Short 10-day course means reconstituted vial is typically used within 5-10 days, well within stability window.
Regulatory status
Epithalon is not FDA-approved for any indication. Available as a research peptide. Used in Russian anti-aging medicine. WADA status: Not specifically listed. Not a controlled substance.
Put it to work
Calculate, log & track
Open Epithalon straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.
Open Epithalon in the app →Go deeper
The guide & community
The complete Epithalon walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.
Join the community ↗